Arca Biopharma Nearly Quintuples On Plans To Test A Coronavirus Drug

·2 min read
Arca Biopharma Nearly Quintuples On Plans To Test A Coronavirus Drug

Shares of Arca Biopharma nearly quintupled in value Thursday after the biotech company announced it would develop a coronavirus treatment for patients with abnormal blood clotting.